A phase 2a trial of brepocitinib for cicatricial alopecia.
David E, Shokrian N, Del Duca E, Meariman M, Dubin C, Hawkins K, Andrews E, Sikand S, Singer G, Oemar B, Estrada Y, Bose S, Pulsinelli J, Mahling P, Da Rosa JC, Ungar B, Peeva E, Guttman-Yassky E.
David E, et al. Among authors: hawkins k.
J Am Acad Dermatol. 2024 Oct 24:S0190-9622(24)03043-3. doi: 10.1016/j.jaad.2024.09.073. Online ahead of print.
J Am Acad Dermatol. 2024.
PMID: 39461505
Free article.